Johnson & Johnson Says Its Booster Shot Provides Increased Protection From COVID-19

Johnson & Johnson shared data from the Phase 3 trial of its booster shot on Tuesday indicating a booster shot at six months provided a 12-fold increase in antibodies.

Johnson & Johnson shared data from its Phase 3 trial of the company’s booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.

(Image credit: Eva Marie Uzctegui/Bloomberg via Getty Images)

Source

Leave a Reply

Your email address will not be published. Required fields are marked *